Biotech ETFs have been the focus of many investors this week after Valeant Pharmaceuticals Intl. Inc. (NYSE: VRX) shares dropped more than 46%...
There's one tech-related area that's particularly attractive to investors right now. And it's an industry that Wall Street had all but written...
Biotech stocks have gotten crushed in recent weeks, with the Nasdaq Biotechnology Index falling 15.5% in the last month and 25% from its July...
Martin Shkreli, CEO of Turing Pharmaceuticals, made news this week when he announced he would raise the price of a medication his company had...
Biotech stocks have seriously outperformed the markets in 2015, and our favorite biotech ETF has been one of the biggest winners. In...
Last week on our roundup of the 2015 top stocks to invest in, we highlighted biotech stocks for their explosive growth in 2015 and their...
There are more than 1,000 biotech companies in North America alone. They cover a wide range of sectors including pharmaceuticals, biologics,...
